Cancer Sci. 2025 Jan;116(1):277. doi: 10.1111/cas.16390. Epub 2024 Oct 30.
C. Di Stefano, G. Marfe, M. M. Trawinska, P. Sinibaldi-Salimei, R. Silvestri, S. Amadori and E. Abruzzese, "Pyrrolo[1,2-b][1,2,5]benzothiadiazepines (PBTDs) Exert Their Anti-proliferative Activity by Interfering With Akt-mTOR Signaling and bax:bcl-2 Ratio Modulation in Cells From Chronic Myeloid Leukemic Patients," Cancer Science 101, no. 4 (2010): 991-1000, https://doi.org/10.1111/j.1349-7006.2010.01490.x. The above article, published online on 07 January 2010 in Wiley Online Library (wileyonlinelibrary.com), has been retracted by agreement between the journal Editor-in-Chief, Masanori Hatakeyama; the Japanese Cancer Association; and John Wiley & Sons Australia, Ltd. The retraction has been agreed due to several instances of duplications of western blot bands observed in Figures 3, 4, 5 and 8. Furthermore, splicing and deletion of bands was uncovered in Figures 4 and 7 respectively. Finally, western blot bands presented in Figure 4 was also found published earlier in another article. The authors provided partial raw data but the inconsistencies found could not be resolved on this basis. Due to the extent and nature of the duplications, the editors consider the results and conclusions of this study invalid.
C. 迪·斯特凡诺、G. 马尔费、M. M. 特拉温斯卡、P. 西尼巴尔迪 - 萨利梅伊、R. 西尔维斯特里、S. 阿马多里和E. 阿布鲁泽塞,“吡咯并[1,2 - b][1,2,5]苯并噻二氮杂卓(PBTDs)通过干扰慢性髓性白血病患者细胞中的Akt - mTOR信号传导和bax:bcl - 2比值调节发挥其抗增殖活性”,《癌症科学》101卷,第4期(2010年):991 - 1000页,https://doi.org/10.1111/j.1349 - 7006.2010.01490.x。上述文章于2010年1月7日在线发表于威利在线图书馆(wileyonlinelibrary.com),已根据期刊主编武山正典、日本癌症协会和约翰威利父子澳大利亚有限公司之间的协议撤回。撤回是由于在图3、4、5和8中观察到多次蛋白质免疫印迹条带重复的情况。此外,分别在图4和7中发现了条带的拼接和缺失。最后,图4中呈现的蛋白质免疫印迹条带也被发现在另一篇文章中更早发表。作者提供了部分原始数据,但在此基础上发现的不一致之处无法得到解决。由于重复的程度和性质,编辑们认为这项研究的结果和结论无效。